These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 38567080)

  • 1. Comparative analysis of the efficacy of vaccines using structural protein subunits of the severe fever with thrombocytopenia syndrome virus.
    Kim S; Jeon K; Choi H; Jeong DE; Kang JG; Cho NH
    Front Microbiol; 2024; 15():1348276. PubMed ID: 38567080
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Vaccination with single plasmid DNA encoding IL-12 and antigens of severe fever with thrombocytopenia syndrome virus elicits complete protection in IFNAR knockout mice.
    Kang JG; Jeon K; Choi H; Kim Y; Kim HI; Ro HJ; Seo YB; Shin J; Chung J; Jeon YK; Kim YS; Lee KH; Cho NH
    PLoS Negl Trop Dis; 2020 Mar; 14(3):e0007813. PubMed ID: 32196487
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A rabies virus vectored severe fever with thrombocytopenia syndrome (SFTS) bivalent candidate vaccine confers protective immune responses in mice.
    Tian L; Yan L; Zheng W; Lei X; Fu Q; Xue X; Wang X; Xia X; Zheng X
    Vet Microbiol; 2021 Jun; 257():109076. PubMed ID: 33957572
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Potent immunogenicity and neutralization of recombinant adeno-associated virus expressing the glycoprotein of severe fever with thrombocytopenia virus.
    Shimoyama T; Oba M; Takemae H; Omatsu T; Tani H; Mizutani T
    J Vet Med Sci; 2024 Feb; 86(2):228-238. PubMed ID: 38143087
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A full-length glycoprotein mRNA vaccine confers complete protection against severe fever with thrombocytopenia syndrome virus, with broad-spectrum protective effects against bandaviruses.
    Lu J; Liu J; Wu Y; He X; Gao X; Chen X; Chen S; Zhu X; Peng Y; Xiao G; Pan X
    J Virol; 2024 Jul; 98(7):e0076924. PubMed ID: 38829138
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nucleocapsid protein-specific IgM antibody responses in the disease progression of severe fever with thrombocytopenia syndrome.
    Wang G; Chang H; Jia B; Liu Y; Huang R; Wu W; Hao Y; Yan X; Xia J; Chen Y; Wu C
    Ticks Tick Borne Dis; 2019 Apr; 10(3):639-646. PubMed ID: 30824322
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Adenovirus type 5-expressing Gn induces better protective immunity than Gc against SFTSV infection in mice.
    Qian H; Tian L; Liu W; Liu L; Li M; Zhao Z; Lei X; Zheng W; Zhao Z; Zheng X
    NPJ Vaccines; 2024 Oct; 9(1):194. PubMed ID: 39426985
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An mRNA-Based Multiple Antigenic Gene Expression System Delivered by Engineered
    Park JY; Hewawaduge C; Sivasankar C; Lloren KKS; Oh B; So MY; Lee JH
    Pharmaceutics; 2023 Apr; 15(5):. PubMed ID: 37242581
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Recombinant Human Adenovirus Type 5 Co-expressing RABV G and SFTSV Gn Induces Protective Immunity Against Rabies Virus and Severe Fever With Thrombocytopenia Syndrome Virus in Mice.
    Zhao Z; Zheng W; Yan L; Sun P; Xu T; Zhu Y; Liu L; Tian L; He H; Wei Y; Zheng X
    Front Microbiol; 2020; 11():1473. PubMed ID: 32695091
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy of T-705 (Favipiravir) in the Treatment of Infections with Lethal Severe Fever with Thrombocytopenia Syndrome Virus.
    Tani H; Fukuma A; Fukushi S; Taniguchi S; Yoshikawa T; Iwata-Yoshikawa N; Sato Y; Suzuki T; Nagata N; Hasegawa H; Kawai Y; Uda A; Morikawa S; Shimojima M; Watanabe H; Saijo M
    mSphere; 2016; 1(1):. PubMed ID: 27303697
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nucleoside-Modified mRNA Vaccines Protect IFNAR
    Appelberg S; John L; Pardi N; Végvári Á; Bereczky S; Ahlén G; Monteil V; Abdurahman S; Mikaeloff F; Beattie M; Tam Y; Sällberg M; Neogi U; Weissman D; Mirazimi A
    J Virol; 2022 Feb; 96(3):e0156821. PubMed ID: 34817199
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A highly attenuated vaccinia virus strain LC16m8-based vaccine for severe fever with thrombocytopenia syndrome.
    Yoshikawa T; Taniguchi S; Kato H; Iwata-Yoshikawa N; Tani H; Kurosu T; Fujii H; Omura N; Shibamura M; Watanabe S; Egawa K; Inagaki T; Sugimoto S; Phanthanawiboon S; Harada S; Yamada S; Fukushi S; Morikawa S; Nagata N; Shimojima M; Saijo M
    PLoS Pathog; 2021 Feb; 17(2):e1008859. PubMed ID: 33534867
    [TBL] [Abstract][Full Text] [Related]  

  • 13. SFTSV Gn-Head mRNA vaccine confers efficient protection against lethal viral challenge.
    Kim D; Lai CJ; Cha I; Kang S; Yang WS; Choi Y; Jung JU
    J Med Virol; 2023 Nov; 95(11):e29203. PubMed ID: 37909776
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Difference in Intraspecies Transmissibility of Severe Fever with Thrombocytopenia Syndrome Virus Depending on Abrogating Type 1 Interferon Signaling in Mice.
    Oh B; Park SC; Yang MS; Yang D; Ham G; Tark D; You MJ; Oh SI; Kim B
    Viruses; 2024 Mar; 16(3):. PubMed ID: 38543766
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characterization of antibodies targeting severe fever with thrombocytopenia syndrome virus glycoprotein Gc.
    Sano K; Kimura M; Sataka A; Hasegawa H; Tani H; Suzuki T
    Arch Virol; 2024 Feb; 169(3):40. PubMed ID: 38308735
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Single dose of a rVSV-based vaccine elicits complete protection against severe fever with thrombocytopenia syndrome virus.
    Dong F; Li D; Wen D; Li S; Zhao C; Qi Y; Jangra RK; Wu C; Xia D; Zhang X; Deng F; Chandran K; Zou Z; Yuan F; Zheng A
    NPJ Vaccines; 2019; 4():5. PubMed ID: 30701094
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pathogenicity of severe fever with thrombocytopenia syndrome virus in mice regulated in type I interferon signaling: Severe fever with thrombocytopenia and type I interferon.
    Park SC; Park JY; Choi JY; Lee SG; Eo SK; Oem JK; Tark DS; You M; Yu DH; Chae JS; Kim B
    Lab Anim Res; 2020; 36():38. PubMed ID: 33102200
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A single immunization with MVA expressing GnGc glycoproteins promotes epitope-specific CD8+-T cell activation and protects immune-competent mice against a lethal RVFV infection.
    López-Gil E; Lorenzo G; Hevia E; Borrego B; Eiden M; Groschup M; Gilbert SC; Brun A
    PLoS Negl Trop Dis; 2013; 7(7):e2309. PubMed ID: 23875044
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Severe fever with thrombocytopenia virus glycoproteins are targeted by neutralizing antibodies and can use DC-SIGN as a receptor for pH-dependent entry into human and animal cell lines.
    Hofmann H; Li X; Zhang X; Liu W; Kühl A; Kaup F; Soldan SS; González-Scarano F; Weber F; He Y; Pöhlmann S
    J Virol; 2013 Apr; 87(8):4384-94. PubMed ID: 23388721
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Modeling Severe Fever with Thrombocytopenia Syndrome Virus Infection in Golden Syrian Hamsters: Importance of STAT2 in Preventing Disease and Effective Treatment with Favipiravir.
    Gowen BB; Westover JB; Miao J; Van Wettere AJ; Rigas JD; Hickerson BT; Jung KH; Li R; Conrad BL; Nielson S; Furuta Y; Wang Z
    J Virol; 2017 Feb; 91(3):. PubMed ID: 27881648
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.